These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22971615)

  • 1. Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency.
    Kim JW; Oh MM; Park MG; Park JY; Bae JH; Kim JJ; Moon DG
    Int J Impot Res; 2013 Jan; 25(1):29-33. PubMed ID: 22971615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study.
    Yassin AA; Saad F; Diede HE
    Andrologia; 2006 Apr; 38(2):61-8. PubMed ID: 16529577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome.
    Park MG; Yeo JK; Cho DY; Kim JW; Kim JW; Oh MM; Kim JJ; Moon du G
    J Sex Med; 2015 Apr; 12(4):966-74. PubMed ID: 25648342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study).
    Buvat J; Montorsi F; Maggi M; Porst H; Kaipia A; Colson MH; Cuzin B; Moncada I; Martin-Morales A; Yassin A; Meuleman E; Eardley I; Dean JD; Shabsigh R
    J Sex Med; 2011 Jan; 8(1):284-93. PubMed ID: 20704642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.
    Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H
    J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
    Hwang TI; Chen HE; Tsai TF; Lin YC
    Int J Impot Res; 2006; 18(4):400-4. PubMed ID: 16395321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined tadalafil and α-blocker therapy for benign prostatic hyperplasia in patients with erectile dysfunction: a multicenter, prospective study.
    Lee JY; Park SY; Jeong TY; Moon HS; Kim YT; Yoo TK; Choi HY; Park HY; Lee SW
    J Androl; 2012; 33(3):397-403. PubMed ID: 21868753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
    Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale.
    Rosen RC; Allen KR; Ni X; Araujo AB
    Eur Urol; 2011 Nov; 60(5):1010-6. PubMed ID: 21855209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone.
    Garcia JA; Sanchez PE; Fraile C; Escovar P
    Andrologia; 2011 Oct; 43(5):293-6. PubMed ID: 21919947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan improves erectile dysfunction in diabetic patients: a clinical trial.
    Chen Y; Cui S; Lin H; Xu Z; Zhu W; Shi L; Yang R; Wang R; Dai Y
    Int J Impot Res; 2012; 24(6):217-20. PubMed ID: 22931760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction.
    La Vignera S; Condorelli R; Vicari E; D'Agata R; Calogero AE
    J Androl; 2012; 33(2):170-5. PubMed ID: 21546612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Choice of treatment of erectile dysfunction associated with hypogonadism].
    Aliaev IuG; Vinarov AZ; Akhvlediani ND
    Urologiia; 2010; (4):37-8, 40-2. PubMed ID: 20967981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED].
    Li GY; Liang JH; Meng ZB; Huang CC; Liang SK; Wei GQ; Shen SL; Zhu CH; Zhang X; Song WR
    Zhonghua Nan Ke Xue; 2013 Jul; 19(7):630-3. PubMed ID: 23926681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.